Prostaglandin E2 Induces the Final Maturation of IL-12-Deficient CD1a+CD83+ Dendritic Cells: The Levels of IL-12 Are Determined During the Final Dendritic Cell Maturation and Are Resistant to Further Modulation
Open Access
- 15 September 1998
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 161 (6) , 2804-2809
- https://doi.org/10.4049/jimmunol.161.6.2804
Abstract
Activation of immature dendritic cells (DC) in peripheral tissues induces their migration to lymph nodes and their maturation into CD83+ DC, which are able to prime naive T cells. The inflammatory cytokines IL-1β and TNF-α induce mature DC, which can secrete IL-12 and promote the development of Th0/Th1-biased cells. DC maturation factors with a Th2-promoting function have not been described. Here we show that PGE2, although it does not induce final DC maturation by itself, synergizes with IL-1β and TNF-α, and allows their effectiveness at 100-fold lower concentrations. While being phenotypically identical with the DC matured in the presence of high concentrations of IL-1β and TNF-α alone, DC matured in the additional presence of PGE2 show impaired IL-12 production and bias naive Th cell development toward the Th2. The ability of DC to produce IL-12 is also suppressed by IL-10, which in contrast to PGE2, inhibits their maturation. The differences in the ability to produce IL-12, established during the final DC maturation, are stable after the removal of modulatory factors. Importantly, fully mature DC become unsusceptible to PGE2 and IL-10. This indicates that the levels of IL-12 production in vivo, in mature DC interacting with Th cells within the lymph nodes, are mainly predetermined at the stage of immature DC in peripheral tissues. These data imply that the character of pathogen-induced local inflammatory reaction can “instruct” local DC to initiate Th1 or Th2-biased responses.Keywords
This publication has 29 references indexed in Scilit:
- Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cellsEuropean Journal of Immunology, 1995
- Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.The Journal of Experimental Medicine, 1995
- Maturation and Migration of Cutaneous Dendritic Cells.Journal of Investigative Dermatology, 1995
- Structural characteristics of CD40 ligand that determine biological functionSeminars in Immunology, 1994
- The role of interleukin 12 in the immune response, disease and therapyImmunology Today, 1994
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- Interferon-γ- and interleukin-4-producing T cells can be primed on dendritic cellsin vivo and do not require the presence of B cellsEuropean Journal of Immunology, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Interleukin‐10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cellsEuropean Journal of Immunology, 1994
- Viability, Prostaglandin E2Production, and Protein Handling in Normal and Inflamed Human Colonic Mucosa Cultured for up to 48 h in VitroScandinavian Journal of Gastroenterology, 1992